EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response

Aida Najafian, Ashraf Alyasin, Marziyeh Aghahosseini, Sedigheh Hosseinimousa, Seyyedeh Neda Kazemi

Clinical and Experimental Reproductive Medicine · 01.12.2023 · 50 (4) · 285-291

DOI: 10.5653/cerm.2023.06086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Reproductive Medicine, erschienen am 01.12.2023. Verfasst von Aida Najafian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infertility, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Infertility can result from a diminished ovarian reserve, but a potential remedy exists in the form of platelet-rich plasma (PRP) administration. This treatment involves both biological factors and tissue trauma mechanisms, which stimulate folliculogenesis, making it a promising and effective strategy. We assessed the impact of direct PRP injections into the ovaries on the fertility outcomes of women classified as poor responders.

Methods

A quasi-experimental study was conducted from April 2021 to December 2022, focusing on patients classified as POSEIDON grade 3 or 4. PRP injections were administered into both ovaries. After 3 months, data were collected on anti-Müllerian hormone (AMH) level, follicle-stimulating hormone (FSH) level, and the numbers of oocytes, mature oocytes, and good-quality embryos following ovarian stimulation. We then compared the data from before and after PRP injection.

Results

This study included 50 women, with a mean of 39 years (interquartile range [IQR], 35 to 43) and 4 years (IQR, 2 to 6) for age and infertility duration, respectively. FSH levels decreased after treatment, while AMH levels and the numbers of oocytes, metaphase II oocytes, and high-quality embryos increased. However, only the increase in high-quality embryos was significant. The pregnancy and spontaneous pregnancy rates were 20% and 14%, respectively. Notably, women with secondary infertility exhibited a significantly higher pregnancy rate than those with primary infertility.

Conclusion

Ample evidence suggests that PRP can enhance ovarian function. However, further studies are needed to identify the appropriate candidates for this procedure, establish the optimal PRP preparation method, and standardize the procedure for its adjuvant use in assisted reproductive technology cycles.

Schlagwörter

Stichwörter der Autor:innen

Assisted reproductive technologyInfertilityOocytesOvaryPlatelet-rich plasmaPregnancy

Autor:innen und Institutionen

  • Department of Infertility, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran.
  • Department of Obstetrics and Gynecology and Female Infertility Unit, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Obstetrics and Gynecology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Najafian, A., Alyasin, A., Aghahosseini, M., Hosseinimousa, S., & Kazemi, S. N. (2023). Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response. Clinical and Experimental Reproductive Medicine, 50(4), 285-291. https://doi.org/10.5653/cerm.2023.06086

Vancouver

Najafian A, Alyasin A, Aghahosseini M, Hosseinimousa S, Kazemi SN. Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response. Clinical and Experimental Reproductive Medicine. 2023;50(4):285-291. doi:10.5653/cerm.2023.06086

BibTeX
@article{Najafian2023,
  author = {Najafian, Aida and Alyasin, Ashraf and Aghahosseini, Marziyeh and Hosseinimousa, Sedigheh and Kazemi, Seyyedeh Neda},
  title = {Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response},
  journal = {Clinical and Experimental Reproductive Medicine},
  year = {2023},
  volume = {50},
  number = {4},
  pages = {285--291},
  doi = {10.5653/cerm.2023.06086}
}
Kostenlos starten →